Clinical Trial Update: Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether adding valsartan affects morbidity and mortality in patients with hypertension and ischemic heart disease; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Ischemic Heart Disease
• Stroke

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Kyoto Prefectural University of Medicine | Conditions: Hypertension, Ischemic Heart Disease | Phase 4 | Status: COMPLETED | Results posted: 2012-12-12